Seelos Therapeutics Vs. Citius Pharmaceuticals Industry Stock Comparison

Sell

18

SEEL
Seelos Therapeutics

Last Price:

0.39

Seasonality Move:

30.44%

Sell

23

CTXR
Citius Pharmaceuticals

Last Price:

0.16

Seasonality Move:

21.66%

Sell

18

Seelos Therapeutics (SEEL) is a Sell

Is Seelos Therapeutics a Buy, Sell or Hold?

The current Seelos Therapeutics [SEEL] share price is $0.39. The Score for SEEL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
SEEL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

23

Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

The current Citius Pharmaceuticals [CTXR] share price is $0.17. The Score for CTXR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
CTXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SEEL Stock Price Chart

What is Seelos Therapeutics's stock price today?

The Seelos Therapeutics share price today is $0.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing selling pressure, which indicates risk of future bearish movement.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

The Citius Pharmaceuticals share price today is $0.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.

SEEL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.27	Sell
Relative Strength Index (14 RSI):	24.51	Sell
Chaikin Money Flow:	-37507	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.6 - 1.38)	Sell
Bollinger Bands (100):	(-0.11 - 1.87)	Sell

CTXR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.06	Sell
Relative Strength Index (14 RSI):	28.66	Sell
Chaikin Money Flow:	-468685	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.26 - 0.42)	Sell
Bollinger Bands (100):	(0.36 - 0.76)	Sell

SEEL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.65	Sell
20-day SMA:	0.88	Sell
50-day SMA:	1.35	Sell
200-day SMA:	2.48	Sell
8-day EMA:	0.64	Sell
20-day EMA:	0.91	Sell
50-day EMA:	1.13	Sell
200-day EMA:	16.7	Sell

CTXR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.27	Sell
20-day SMA:	0.33	Sell
50-day SMA:	0.4	Sell
200-day SMA:	0.64	Sell
8-day EMA:	0.24	Sell
20-day EMA:	0.31	Sell
50-day EMA:	0.4	Sell
200-day EMA:	0.61	Sell

Seelos Therapeutics Earnings Growth & SEEL Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.23 per share.

Seelos Therapeutics Technical Analysis

	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18
	Nov
	05	06	07	08	11	12	13	14	15	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Citius Pharmaceuticals Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):